Most women who die from cervical cancer, particularly in developing countries, are in the prime of their life. They may be raising children, caring for their family, and contributing to the social and economic life of their town or village. Their death is both a personal tragedy, and a sad and unnecessary loss to their family and their community. Unnecessary, because there is compelling evidence, as this Guide makes clear, that cervical cancer is one of the most preventable and treatable forms of cancer, as long as it is detected early and managed effectively. Unfortunately, the majority of women in developing countries still do not have access to cervical cancer prevention programmes. The consequence is that, often, cervical cancer is not detected until it is too late to be cured. An urgent effort is required if this situation is to be corrected. This Guide is intended to help those responsible for providing services aimed at reducing the burden posed by cervical cancer for women, communities and health systems. It focuses on the knowledge and skills needed by health care providers, at different levels of care.

A Practical Approach to Cervical Cancer Screening Techniques assists postgraduate trainees and practising gynaecologists in the prevention of cervical carcinoma by guiding them through screening methods for detecting pre-invasive lesions. This book is comprised of 17 chapters which emphasise the need for cervical screening to prevent invasive carcinoma, by diagnosing and treating women with high-grade cervical lesions. The major factors in the occurrence of cervical cancer, such as active metaplasia in the transformation zone, exposure to oncogen, and immune status of the individual are explained in detail. The criteria for a screening test and the various screening techniques available for cervical cancer, such as pap smear, liquid-based cytology, HPV testing, polar probe, laser-induced fluorescence, speculoscopy and cervicography are also discussed. Colposcopy and the use of polarprob, the portable optoelectronic instrument that detects the existence of cervical cancer and precancer, are also described clearly in this concise guide to cervical cancer screening. Key Features Covers major factors influencing the occurrence of cervical cancer Details various techniques for screening Guide to performing, interpreting and logging colposcopy Introduction to use of polarprob in screening 68 full colour images and illustrations

Cancer ranks second only to heart disease as a leading cause of death in the United States, making it a tremendous burden in years of life lost, patient suffering, and economic costs. Fulfilling the Potential for Cancer Prevention and Early Detection reviews the proof that we can dramatically reduce cancer rates. The National Cancer Policy Board, part of the Institute of Medicine, outlines a national strategy to realize the promise of cancer prevention and early detection, including specific and wide-ranging recommendations. Offering a wealth of information and directly addressing major controversies, the book includes: A detailed look at how significantly cancer could be reduced through lifestyle changes, evaluating approaches used to alter eating, smoking, and exercise habits. An analysis of the intuitive notion that screening for cancer leads to improved health outcomes, including a discussion of screening methods, potential risks, and current recommendations. An examination of cancer prevention and control opportunities in primary health care delivery settings, including a review of interventions aimed at improving provider performance. Reviews of professional education and training programs, research trends and opportunities, and federal programs that support cancer prevention and early detection. This in-depth volume will be of interest to policy analysts, cancer and public health specialists, health care administrators and providers, researchers, insurers, medical journalists, and patient advocates.

Cervical cancer is a malignancy of the cervix. World-wide, it is the second most common cancer of women. It may be present with vaginal bleeding but symptoms may be absent until the cancer is in advanced stages, which has made cervical cancer the focus of intense screening efforts. Most scientific studies point to human papillomavirus (HPV) infection responsible for 90% of the cases of cervical cancer. There are 7 most common types of HPV - 16, 18, 31, 33, 42, 52 and 58. Types 16 and 18 being the most common cause of the cancer. Treatment is with surgery (including local exicision) in early stages and chemotherapy and radiotherapy in advanced stages of the disease. This book presents cutting edge research in this field. This involves, programs for cancer screening, alternative approaches to cervical cancer prevention, HPV/Co-Infections and Host Genetic Profiles, Small Cell Carcinoma of the Uterine Cervix, Indicators of HPV-induced carcinogenesis, functional genomics as a tool for understanding cervical cancer, histone deacetylase inhibitors, Chinese women and cervical cancer and cervical cancer in Northeastern Thailand.

This WHO and HRP guideline is designed to help countries make faster progress, more equitably, on the screening and treatment of cervical cancer. It includes some important shifts in WHO’s recommended approaches to cervical screening, and includes a total of 23 recommendations and 7 good practice statements. Among the 23 recommendations, 6 are identical for both the general population of women and for women living with HIV and 12 are different and specific for each population. Among the 7 good practice statements, 3 are identical for both the general population of women and for women living with HIV and 2 are different and specific for each population.

Recoge: 1. Epidemiological guidelines for quality assurance in cervical cancer screening - 2. Methods for screening and diagnosis - 3. Laboratory guidelines and quality assurance practices for cytology - 4. Techniques and quality assurance guidelines for histopathology - 5. Management of abnormal cervical cytology - 6. Key performance indicators - 7. Annexes.